Home > Healthcare > Biotechnology > Biotechnology R&D > Hematopoietic Stem Cell Transplantation Market

Hematopoietic Stem Cell Transplantation Market Size

Report ID: GMI6276
Published Date: Jul 2023
Report Format: PDF

Download Free Sample

Hematopoietic Stem Cell Transplantation Market Size

Hematopoietic Stem Cell Transplantation Market size was valued to be USD 2.6 billion in 2022 and is expected to reach USD 6.2 billion in 2032 with a CAGR of 9.3% by 2032 due to the increasing incidence of leukemia, rising success rate of transplantation, and technological advancements in the transplantation procedures.

To get key market trends

Download Free Sample

Hematopoietic stem cells (HSCs) are multipotent precursors that have self-renewal capacity and the ability to regenerate all the different cell types that comprise the blood-forming system. Hematopoietic stem cell transplantation (HSCT) includes the intravenous infusion of hematopoietic stem cells to reestablish blood cell production in patients whose immune system or bone marrow are damaged. This technique is used to treat numerous malignant and non-malignant diseases such as leukemia, lymphoma, sickle cell disease, and congenital neutropenia.

Hematopoietic Stem Cell Transplantation Market Report Attributes
Report Attribute	Details
Base Year:	2022
Hematopoietic Stem Cell Transplantation Market Size in 2022:	USD 2.6 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	9.3%
2032 Value Projection:	USD 6.2 Billion
Historical Data for:	2018 to 2022
No. of Pages:	254
Tables, Charts & Figures:	439
Growth Drivers:	Increasing prevalence of haematological disorders Rising success rate of transplantation procedures Increasing number of geriatric patients Advancements in HSCT techniques Increasing awareness among physicians and patients about the benefits of HSCT Expanding stem cell donor registries
Pitfalls & Challenges:	High cost of HSCT procedure Adverse effects associated with the transplants Availability of alternative therapies Disparities in reimbursement policies and insurance coverage for HSCT Difficulty associated with finding donors

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global market size for hematopoietic stem cell transplantation was valued to be USD 2.6 billion in 2022 and is expected to record a CAGR of 9.3% by 2032, owing to the increasing incidence of leukemia, rising success rate of transplantation, and technological advancements.

The autologous transplant therapy segment held the largest market share of 57.6% in 2022 as it reduces the time and resources required for donor search and facilitates a quicker transplantation process.

North America market is expected to reach USD 2.2 billion by 2032 because the region boasts a well-developed and advanced healthcare infrastructure, including specialized transplant centers and comprehensive cancer centers.

Pluristem Therapeutics Inc., Sanofi, Taiga Biotechnologies, Inc., CellGenix GmbH, Novartis AG, Regen Biopharma Inc., Kiadis Pharma, Marker Therapeutics, Inc., Escape Therapeutics, Inc., GlaxoSmithKline plc, Merck KGaA, Bluebird Bio, Inc., and Talaris Therapeutics.